SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1MEF - Registration adding securities to prior Form S-1 registration [Rule 462(b)]:
SEC Accession No. 0001193125-20-270502
Filing Date
2020-10-15
Accepted
2020-10-15 21:17:23
Documents
5
Effectiveness Date
2020-10-15

Document Format Files

Seq Description Document Type Size
1 S-1MEF d36779ds1mef.htm S-1MEF 40017
2 EX-5.1 d36779dex51.htm EX-5.1 7487
3 EX-23.1 d36779dex231.htm EX-23.1 1995
4 GRAPHIC g36779dsp5.jpg GRAPHIC 8156
5 GRAPHIC g36779dsp6.jpg GRAPHIC 5398
  Complete submission text file 0001193125-20-270502.txt   69455
Mailing Address 15440 LAGUNA CANYON ROAD IRVINE CA 92618
Business Address 15440 LAGUNA CANYON ROAD IRVINE CA 92618 (949) 409-9820
Tarsus Pharmaceuticals, Inc. (Filer) CIK: 0001819790 (see all company filings)

IRS No.: 814717861 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1MEF | Act: 33 | File No.: 333-249509 | Film No.: 201242639
SIC: 2836 Biological Products, (No Diagnostic Substances)